肝门部胆管癌;手术切除;并发症;总生存期," /> 肝门部胆管癌;手术切除;并发症;总生存期,"/> Hilar cholangiocarcinoma,Surgical resection,Complication,Overall survival,"/>
Chinese Journal of Oncology Prevention and Treatment ›› 2023, Vol. 15 ›› Issue (6): 644-649.doi: 10.3969/j.issn.1674-5671.2023.06.08
Previous Articles Next Articles
CLC Number:
YANG Dalong, LU Haiming, ZHONG Jianhong, QI Lunan, CHEN Zushun, XIANG Bangde, LI Lequn, MA Liang. Factors influencing the efficacy and safety of surgery for hilar cholangiocarcinoma[J].Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 644-649.